Mini Review - Research and Reports in Immunology (2023) Volume 6, Issue 2
MHC Genotyping in Population Genetics: Insights into Genetic Diversity and Evolutionary Relationships
Department of Biomedical Sciences, University of Edinburgh, Edinburgh, United Kingdom.
- *Corresponding Author:
- Sarah Anderson
Department of Biomedical Sciences
University of Edinburgh,
Edinburgh, United Kingdom.
Received:31-Mar-2023, Manuscript No. AARRI-23-97312; Editor assigned: 03-Apr-2023,PreQC No.AARRI-23-97312(PQ); Reviewed:17-Apr-2023,QC No AARRI-23-97312; Revised:22-Apr-2023, Manuscript No. AARRI -23-97312(R); Published:29-Apr-2023,DOI:10.35841/aarrgs-6.2.145
Citation: Anderson S. MHC genotyping in population genetics: insights into genetic diversity and evolutionary relationships. Res Rep Immunol. 2023; 6(2):145
Major histocompatibility complex (MHC) is a group of genes that play a crucial role in the immune system of vertebrates. MHC genes encode for MHC molecules, which present antigenic peptides to T cells, thus enabling the immune system to recognize and destroy foreign pathogens. The polymorphic nature of MHC genes makes them ideal candidates for determining the compatibility between transplant donors and recipients and for understanding the genetic basis of autoimmune diseases. MHC genotyping refers to the process of identifying the specific alleles or haplotypes of MHC genes in an individual or a population. In this article, we will discuss the importance of MHC genotyping, the methods used for MHC genotyping, and the applications of MHC genotyping in medicine and research.
Genotyping, Serology, Transplantation, Autoimmune diseases.
Importance of MHC genotyping:
MHC genes are highly polymorphic, meaning that they have multiple alleles in the population. The diversity in MHC alleles ensures that the immune system can recognize a wide range of pathogens. However, the diversity in MHC alleles also poses a challenge in transplantation, as the recipient's immune system may recognize the transplanted organ as foreign and reject it. Therefore, MHC genotyping is essential for determining the compatibility between the donor and the recipient in organ and tissue transplantation. MHC genotyping can also be used for studying the genetic basis of autoimmune diseases, as certain MHC alleles have been associated with an increased risk of developing autoimmune diseases..
Methods used for MHC genotyping:
There are several methods used for MHC genotyping, including serology, sequence-based typing, and PCR-based methods. Serology involves the use of antibodies to detect MHC molecules on the surface of cells. While serology can identify the broad MHC class I and class II types, it cannot distinguish between individual alleles. Sequence-based typing involves sequencing the entire coding region of MHC genes and comparing the sequence to a database of known alleles. This method provides high-resolution genotyping, but it is time-consuming and expensive. PCR-based methods include polymerase chain reaction (PCR) amplification of specific regions of MHC genes followed by sequencing, hybridization, or restriction fragment length polymorphism analysis. PCR-based methods are faster and less expensive than sequence-based typing, but they may not provide the same level of resolution .
Applications of MHC genotyping:
MHC genotyping has several applications in medicine and research. In transplantation, MHC genotyping is essential for determining the compatibility between the donor and the recipient. The closer the MHC match between the donor and the recipient, the lower the risk of rejection. MHC genotyping can also be used for identifying potential donors for bone marrow transplantation, as a close MHC match between the donor and the recipient is essential for the success of the transplant [3,].
MHC genotyping is also useful for studying the genetic basis of autoimmune diseases. Autoimmune diseases occur when the immune system attacks the body's own tissues, and certain MHC alleles have been associated with an increased risk of developing autoimmune diseases. MHC genotyping can also be used for studying the evolutionary history of populations. As MHC genes are highly polymorphic, they provide a valuable tool for studying the genetic diversity and evolutionary relationships of populations. MHC genotyping can be used to identify the ancestral MHC haplotypes of a population, track the movement of populations, and identify genetic bottlenecks and founder effects .
MHC genotyping is a powerful tool that has revolutionized our understanding of the immune system and its role in health and disease. The diversity in MHC alleles presents a challenge in transplantation, and MHC genotyping is essential for determining the compatibility between the donor and the recipient. In autoimmune disease research, MHC genotyping has helped identify certain MHC alleles that are associated with an increased risk of developing autoimmune diseases, providing valuable insights into the genetic basis of these diseases. MHC genotyping has also been used for studying the evolutionary history of populations, providing a window into the genetic diversity and evolutionary relationships of populations .
The development of MHC genotyping methods has made it possible to identify the specific alleles or haplotypes of MHC genes in an individual or a population. While different methods have different levels of resolution, they all play an important role in MHC genotyping and have contributed to our understanding of the immune system, transplantation, autoimmune diseases, and population genetics. Overall, MHC genotyping is a powerful tool that has broad applications in medicine and research. As technology continues to advance, it is likely that new methods for MHC genotyping will be developed, providing even more detailed insights into the diversity and complexity of MHC genes and their role in health and disease.
- Ennis PD. Rapid cloning of HLA-A, cDNA by using the polymerase chain reaction: frequency and nature of errors produced in amplification. Proc Natl Acad Sci USA. 1990;87: 2833-37.
- Brown JH. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.. Nature 1993;364.
- Cornish AS. Exome screening to identify loss-of-function mutations in the rhesus macaque for development of preclinical models of human disease.. BMC Genomics. 2016;17:170.
- Daza-Vamenta R. Genetic divergence of the rhesus macaque major histocompatibility complex.. Genome Res. 2004; 14: 1501–15.
- Ennis PD. Rapid cloning of cDNA by using the polymerase chain reaction: frequency and nature of errors produced in amplification . Proc Natl Acad Sci U S A.1990; 87: 2833-37.